I MAB's ticker is IMAB and the CUSIP is 44975P103. A total of 55 filers reported holding I MAB in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,120,170 | -55.9% | 6,909,220 | 0.0% | 0.20% | -53.6% |
| Q2 2023 | $20,658,568 | -14.1% | 6,909,220 | -0.7% | 0.44% | +3.0% |
| Q1 2023 | $24,062,369 | -19.9% | 6,954,442 | -3.2% | 0.43% | -32.6% |
| Q4 2022 | $30,024,313 | +4.2% | 7,182,850 | 0.0% | 0.63% | -16.2% |
| Q3 2022 | $28,803,000 | -64.5% | 7,182,850 | 0.0% | 0.76% | -56.5% |
| Q2 2022 | $81,166,000 | -30.4% | 7,182,850 | 0.0% | 1.74% | -28.5% |
| Q1 2022 | $116,649,000 | -65.7% | 7,182,850 | 0.0% | 2.44% | -53.7% |
| Q4 2021 | $340,395,000 | -34.6% | 7,182,850 | 0.0% | 5.26% | -22.8% |
| Q3 2021 | $520,685,000 | -6.3% | 7,182,850 | +8.6% | 6.81% | +19.1% |
| Q2 2021 | $555,427,000 | +73.2% | 6,616,170 | 0.0% | 5.72% | +80.4% |
| Q1 2021 | $320,686,000 | +354.5% | 6,616,170 | +342.1% | 3.17% | +464.9% |
| Q4 2020 | $70,562,000 | +0.3% | 1,496,540 | 0.0% | 0.56% | +5.3% |
| Q3 2020 | $70,382,000 | – | 1,496,540 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EDBI Pte Ltd | 222,136 | $768,591 | 0.86% |
| HHLR ADVISORS, LTD. | 6,954,442 | $24,062,369 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 310,499 | $1,074,327 | 0.30% |
| Maso Capital Partners Ltd | 100,000 | $346 | 0.23% |
| Artal Group S.A. | 850,000 | $2,941 | 0.18% |
| Virtus ETF Advisers LLC | 26,347 | $91,161 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 96,555 | $334 | 0.03% |
| CAXTON ASSOCIATES LP | 53,793 | $186,124 | 0.03% |
| Diametric Capital, LP | 13,924 | $48,177 | 0.02% |
| Tekla Capital Management LLC | 162,580 | $562,527 | 0.02% |